Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-23T15:31:47.040Z Has data issue: false hasContentIssue false
  • English
  • Français

Tobacco dependence and schizophrenia: Tunisian cross-sectional study of 50 cases

Published online by Cambridge University Press:  01 September 2022

M. Jabeur ,
L. Gassab ,
I. Anes ,
A. Ben Haouala ,
F. Zaafrane  and
L. Gaha
M. Jabeur*
Affiliation:
Research laboratory LR 05 ES 10 “Vulnerability to Psychotic Disorders”, Faculty of medicine, University of Monastir, Psychiatry Department, University Hospital Of Monastir, Monastir, Tunisia
L. Gassab
Affiliation:
Research laboratory LR 05 ES 10 “Vulnerability to Psychotic Disorders”, Faculty of medicine, University of Monastir, Psychiatry Department, University Hospital Of Monastir, Monastir, Tunisia
I. Anes
Affiliation:
Research laboratory LR 05 ES 10 “Vulnerability to Psychotic Disorders”, Faculty of medicine, University of Monastir, Psychiatry Department, University Hospital Of Monastir, Monastir, Tunisia
A. Ben Haouala
Affiliation:
Research laboratory LR 05 ES 10 “Vulnerability to Psychotic Disorders”, Faculty of medicine, University of Monastir, Psychiatry Department, University Hospital Of Monastir, Monastir, Tunisia
F. Zaafrane
Affiliation:
Research laboratory LR 05 ES 10 “Vulnerability to Psychotic Disorders”, Faculty of medicine, University of Monastir, Psychiatry Department, University Hospital Of Monastir, Monastir, Tunisia
L. Gaha
Affiliation:
Research laboratory LR 05 ES 10 “Vulnerability to Psychotic Disorders”, Faculty of medicine, University of Monastir, Psychiatry Department, University Hospital Of Monastir, Monastir, Tunisia
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Tobacco-use is currently one of the major public health problems and is more common among patients with schizophrenia.

Objectives

We aimed in this study to estimate the prevalence of smoking in a population of patients with schizophrenia, to assess tobacco dependence and to identify its correlated factors.

Methods

This is a descriptive and analytical cross-sectional study carried out on 50 outpatients at the Department of Psychiatry (Tunisia) over a period of two months. For the data collection, we used: a general questionnaire on sociodemographic characteristics and tobacco consumption and the Fagerström test for nicotine dependence.

Results

All the patients were male with a mean age of 32.7±7.02 years and 84% of them were tobacco consumers. More than half of the sample were single (68%) and had a primary school level (52%). A professional irregularity and low socio-economic level were found successively in 84% and 78% of cases. Half of the patients (52%) were diagnosed with paranoid schizophrenia and 46% of them were treated by atypical antipsychotics. Cigarette dependence was strong or very strong in 82% according to the Fagerstrom test. A positive correlation was found between strong tobacco dependence on the one hand and low socio-economic level, professional irregularity, smoking in a first-degree relative and treatment with a typical neuroleptic on the other hand.

Conclusions

Our study and data from the literature show that subjects with schizophrenia constitute a population of highly dependent smokers. A smoking cessation assistance program for this vulnerable population is a priority to improve their quality of life.

Disclosure

No significant relationships.

Keywords

schizophréniaantipsychoticdependenceTobacco-use
Type
Abstract
Information
European Psychiatry , Volume 65 , Special Issue S1: Abstracts of the 30th European Congress of Psychiatry , June 2022 , pp. S831
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.